Search - tctmd.com

Displaying 1 - 20 of 180

Sort: Relevancy | Date

News Conference News TCT 2025

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Yael L. Maxwell

October 27, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

News Daily News

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

Todd Neale

July 31, 2025

News Daily News

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

L.A. McKeown

July 30, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Daily News

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

L.A. McKeown

February 24, 2025

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Shelley Wood

September 01, 2024

News Conference News ESC 2024

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Shelley Wood

August 31, 2024

News Features

Valvular Heart Disease Has a Diversity Problem

Yael L. Maxwell

July 12, 2024

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

News Conference News CRT 2024

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

L.A. McKeown

March 12, 2024

Advertisement

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

What’s Going to Be Hot at TCT 2025

CVD Still the Leading Cause of Death and Disease Globally

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

April 2025 Dispatch for the CV Team

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

November 2024 Dispatch for the CV Team

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

TCTMD’s Top 10 Most Popular Stories for August 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Valvular Heart Disease Has a Diversity Problem

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content